Stocks of auto OEMs and component makers have fallen sharply due to FII sell-offs and earnings downgrade expectations. The upcoming Union Budget is anticipated to address industry demands for GST rate simplification, hybrid vehicle GST reduction, and improved PLI schemes. Despite superior 1-year returns, the BSE Auto index has struggled over the past six months.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025